Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Xylogenics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Xylogenics

Xylogenics

Seed

Indianapolis-based biotech firm providing eco-friendly bio-solutions in chemical markets.

HQ
Indianapolis, IN, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in Indianapolis, Indiana, Xylogenics is a biotechnology company focused on delivering eco-friendly bio-solutions to the chemical markets. The company's core mission is to redefine fermentation through synthetic biology, offering innovative yeast strains and products tailored for the fuel ethanol and specialty chemicals sectors. Their product lineup includes dry and liquid yeast solutions designed to enhance efficiency and reduce cycle times in biofuel production.

Xylogenics has garnered attention for its pioneering work in yeast genetics, attracting notable investors and industry experts. The company's key achievements include the development of their Gen 1 FX23 and Gen 2 Xcel yeast strains, which have significantly improved production metrics for their clients. By providing sustainable alternatives in the chemical industry, Xylogenics has made a substantial impact on promoting eco-friendly practices and advancing biotechnological innovation.

Xylogenics - Similar Companies

Xylome logo

Xylome

xylome.com

Lygos logo

Lygos

lygos.com

FiberX logo

FiberX

fiberxproducts.com

Solugen logo

Solugen

solugen.com

Pow.bio logo

Pow.bio

pow.bio

Conagen logo

Conagen

Modular Genetics logo

Modular Genetics

Locus Fermentation Solutions logo

Locus Fermentation Solutions

locusfs.com

Xylyx Bio logo

Xylyx Bio

xylyxbio.com

Bluestem Biosciences logo

Bluestem Biosciences

Terra Bioforge logo

Terra Bioforge

terrabioworks.com

Zymochem logo

Zymochem

zymochem.com

Xeno Biosciences logo

Xeno Biosciences

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Xylogenics - Quick Facts

Who are Xylogenics' competitors?

Companies similar to Xylogenics include Xylome, Lygos, FiberX and Solugen.

When was Xylogenics founded?

Xylogenics was founded in 2008.

Where is Xylogenics' headquarters located?

Xylogenics' headquarters is located in Indianapolis, IN, US.

When was Xylogenics' last funding round?

Xylogenics' most recent funding round was for $300k (USD) in December 2010.

How much has Xylogenics raised to-date?

As of Dec 20, 2010, Xylogenics has raised a total of $525k (USD).

How many employees does Xylogenics have?

Xylogenics has 6 employees as of Feb 5, 2024.

Xylogenics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • Synthetic Biology
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Biofuel
  • Yeast
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified